Literature DB >> 20378680

Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment.

Joy Humphreys Clark1, Valerie L Hobson, Sid E O'Bryant.   

Abstract

Previous research has supported the use of percent retention scores in the neuropsychological assessment of memory, and many widely used memory measures provide for the calculation and normative comparison of these scores. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), an increasingly utilized assessment tool for cognitive impairment, provides normative data on delayed memory total raw scores only. The current study was aimed at determining the diagnostic accuracy of a novel percent retention score calculated from RBANS verbal memory subtests (delayed recall minus last learning trial) when distinguishing between normal controls, individuals diagnosed with Mild Cognitive Impairment, and individuals diagnosed with Alzheimer's disease. Results revealed excellent diagnostic accuracy of the RBANS percent retention scores when discriminating between the three groups. Findings suggest that RBANS percent retention scores provide excellent diagnostic accuracy offering supplementary information to clinicians and researchers alike.

Entities:  

Mesh:

Year:  2010        PMID: 20378680     DOI: 10.1093/arclin/acq023

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  7 in total

1.  Normative Data for Derived Measures and Discrepancy Scores for the Uniform Data Set 3.0 Neuropsychological Battery.

Authors:  Paulina V Devora; Samantha Beevers; Andrew M Kiselica; Jared F Benge
Journal:  Arch Clin Neuropsychol       Date:  2019-01-24       Impact factor: 2.813

2.  Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.

Authors:  Dustin B Hammers; Taylor J Atkinson; Bonnie C A Dalley; Kayla R Suhrie; Britney E Beardmore; Lance D Burrell; Kevin P Horn; Kelli M Rasmussen; Norman L Foster; Kevin Duff; John M Hoffman
Journal:  Clin Neuropsychol       Date:  2017-01-12       Impact factor: 3.535

3.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

4.  Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer's disease.

Authors:  Kevin Duff; Kayla R Suhrie; Dustin B Hammers; Ava M Dixon; Jace B King; Vincent Koppelmans; John M Hoffman
Journal:  Clin Neuropsychol       Date:  2021-10-29       Impact factor: 4.373

5.  Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation.

Authors:  Muireann Irish; Brian A Lawlor; Robert F Coen; Shane M O'Mara
Journal:  BMC Neurosci       Date:  2011-08-04       Impact factor: 3.288

6.  Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.

Authors:  Christopher C Abbott; Davin Quinn; Jeremy Miller; Enstin Ye; Sulaiman Iqbal; Megan Lloyd; Thomas R Jones; Joel Upston; Zhi De Deng; Erik Erhardt; Shawn M McClintock
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-17       Impact factor: 4.105

7.  Electroconvulsive therapy treatment responsive multimodal brain networks.

Authors:  Shile Qi; Christopher C Abbott; Katherine L Narr; Rongtao Jiang; Joel Upston; Shawn M McClintock; Randall Espinoza; Tom Jones; Dongmei Zhi; Hailun Sun; Xiao Yang; Jing Sui; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2020-01-06       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.